CytomX Therapeutics, Inc. - Common Stock (CTMX)

CUSIP: 23284F105

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / Common Stock
Shares outstanding
169,491,059
Total 13F shares
24,242,512
Share change
+2,154,656
Total reported value
$440,733,363
Price per share
$18.17
Number of holders
97
Value change
+$42,038,227
Number of buys
60
Number of sells
31

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 23284F105?
CUSIP 23284F105 identifies CTMX - CytomX Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of CTMX - CytomX Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
3.3%
5,512,459
$85,444,000 30 Jun 2017
13F
BVF INC/IL
13F
Company
1.2%
2,026,998
$31,418,000 30 Jun 2017
13F
BlackRock Finance, Inc.
13F
Company
1.1%
1,812,512
$28,093,000 30 Jun 2017
13F
PERCEPTIVE ADVISORS LLC
13F
Company
0.82%
1,390,381
$21,550,000 30 Jun 2017
13F
VANGUARD GROUP INC
13F
Company
0.55%
924,138
$14,323,000 30 Jun 2017
13F
EcoR1 Capital, LLC
13F
Company
0.47%
794,969
$12,322,000 30 Jun 2017
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
0.45%
756,822
$11,731,000 30 Jun 2017
13F
Redmile Group, LLC
13F
Company
0.41%
698,392
$10,825,000 30 Jun 2017
13F
Numeric Investors LLC
13F
Company
0.37%
627,770
$9,730,000 30 Jun 2017
13F
Tekla Capital Management LLC
13F
Company
0.31%
530,092
$8,216,000 30 Jun 2017
13F
Opaleye Management Inc.
13F
Company
0.27%
460,000
$7,130,000 30 Jun 2017
13F
STATE STREET CORP
13F
Company
0.26%
446,315
$6,914,000 30 Jun 2017
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.24%
410,900
$6,369,000 30 Jun 2017
13F
FRANKLIN RESOURCES INC
13F
Company
0.2%
333,500
$5,169,000 30 Jun 2017
13F
NORTHERN TRUST CORP
13F
Company
0.19%
316,586
$4,907,000 30 Jun 2017
13F
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
0.17%
290,415
$4,501,000 30 Jun 2017
13F
VHCP Management II, LLC
13F
Company
0.17%
288,915
$4,478,000 30 Jun 2017
13F
JPMORGAN CHASE & CO
13F
Company
0.14%
242,750
$3,763,000 30 Jun 2017
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.14%
242,690
$3,762,000 30 Jun 2017
13F
Spark Investment Management LLC
13F
Company
0.14%
236,900
$3,671,000 30 Jun 2017
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.14%
234,763
$3,638,000 30 Jun 2017
13F
Cormorant Asset Management, LP
13F
Company
0.14%
230,000
$3,565,000 30 Jun 2017
13F
SPHERA FUNDS MANAGEMENT LTD.
13F
Company
0.12%
200,000
$3,100,000 30 Jun 2017
13F
S.c.a. Candriam
13F
Individual
0.12%
195,000
$3,023,000 30 Jun 2017
13F
Casdin Capital, LLC
13F
Company
0.1%
177,500
$2,751,000 30 Jun 2017
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.1%
169,552
$2,628,000 30 Jun 2017
13F
EVENTIDE ASSET MANAGEMENT, LLC
13F
Company
0.09%
150,000
$2,325,000 30 Jun 2017
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.08%
127,776
$1,980,000 30 Jun 2017
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0.07%
125,890
$1,951,000 30 Jun 2017
13F
Invesco Ltd.
13F
Company
0.07%
121,683
$1,886,000 30 Jun 2017
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.07%
117,642
$1,824,000 30 Jun 2017
13F
Bank of New York Mellon Corp
13F
Company
0.07%
115,777
$1,794,000 30 Jun 2017
13F
Private Advisor Group, LLC
13F
Company
0.06%
100,000
$1,640,000 30 Jun 2017
13F
DEUTSCHE BANK AG\
13F
Company
0.06%
105,283
$1,631,000 30 Jun 2017
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.06%
104,804
$1,625,000 30 Jun 2017
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.06%
102,497
$1,589,000 30 Jun 2017
13F
NORDEA INVESTMENT MANAGEMENT AB
13F
Company
0.06%
93,613
$1,451,000 30 Jun 2017
13F
Vident Investment Advisory, LLC
13F
Company
0.05%
83,392
$1,293,000 30 Jun 2017
13F
Foundry Partners, LLC
13F
Company
0.05%
76,498
$1,186,000 30 Jun 2017
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.04%
73,690
$1,142,000 30 Jun 2017
13F
MORGAN STANLEY
13F
Company
0.04%
73,350
$1,137,000 30 Jun 2017
13F
TFS CAPITAL LLC
13F
Company
0.04%
61,010
$946,000 30 Jun 2017
13F
Iguana Healthcare Management, LLC
13F
Company
0.04%
60,000
$930,000 30 Jun 2017
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.04%
59,516
$922,000 30 Jun 2017
13F
TEACHERS ADVISORS, LLC
13F
Company
0.03%
52,211
$809,000 30 Jun 2017
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.03%
51,430
$797,000 30 Jun 2017
13F
STRS OHIO
13F
Company
0.03%
47,600
$737,000 30 Jun 2017
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.02%
41,233
$639,000 30 Jun 2017
13F
HARBOURVEST PARTNERS LLC
13F
Company
0.02%
39,199
$608,000 30 Jun 2017
13F
Of The University Of California Regents
13F
Individual
0.02%
36,499
$566,000 30 Jun 2017
13F

Institutional Holders of CytomX Therapeutics, Inc. - Common Stock (CTMX) as of Q3 2017

As of 30 Sep 2017, CytomX Therapeutics, Inc. - Common Stock (CTMX) was held by 97 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,242,512 shares. The largest 10 holders included FMR LLC, BVF INC/IL, BlackRock Inc., PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, STATE STREET CORP, EcoR1 Capital, LLC, DEERFIELD MANAGEMENT CO, MILLENNIUM MANAGEMENT LLC, and RENAISSANCE TECHNOLOGIES LLC. This page lists 97 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2017 vs Q2 2017 Across Filers

Q2 2017 holders
89
Q3 2017 holders
97
Holder diff
8
Investor Q2 2017 Shares Q3 2017 Shares Share Diff Share Chg % Q2 2017 Value $ Q3 2017 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.